)
Evotec (EVT) investor relations material
Evotec Morgan Stanley 24th Annual Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Initial reflections and organizational strengths
Scientific expertise and breadth of knowledge are key differentiators, offering a wide range of services.
The company's story and value proposition are complex, requiring clearer market communication.
An outside-in perspective enables objective questioning and process simplification.
Transparent internal dialogue is used to drive future performance.
Market environment and customer sentiment
Sector funding is improving, especially in later-stage pipeline investments, boosting market confidence.
Commercial indicators, including year-on-year sales, show positive momentum.
Customers are cautiously optimistic, focusing investments for maximum returns.
Horizon transformation program
Horizon targets €75 million in savings, with 20–30% impact expected in 2026.
Initiatives include site consolidation, centers of expertise, commercial investment, and process simplification.
The program aims to create a stable, growth-oriented platform beyond cost savings.
- Revenue and profitability declined sharply, with losses deepening and guidance lowered for 2026.EVT
Q2 2026 - Accelerating growth with innovation, cost savings, and a high-value asset pipeline.EVT
Company presentation - 2026 outlook cut as partnership delays weigh, but core business segments show strong momentum.EVT
Q2 2026 TU - Annual meeting to elect Trustees, review governance, and address audit and risk oversight.EVT
Proxy filing - Operational excellence, pipeline growth, and asset-light strategy drive sustainable value creation.EVT
Company presentation - Biologics growth, cost savings, and Horizon transformation drive high-end 2025 results.EVT
Q4 2025 - Biologics growth and €40m cost savings offset R&D decline, supporting 2024 guidance.EVT
Q3 2024 - Revenue up 2%, but losses deepened and restructuring accelerated in H1 2024.EVT
Q2 2024 - Revenue fell 4% but Biologics grew 10–11%, with guidance and cost savings reaffirmed.EVT
Q1 2025
Next Evotec earnings date
Next Evotec earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)